ATOSSA THERAPEUTICS INC. - COMMON STOCK
1,8000
28-марта-24 15:59:55
15 мин. задержка
Акции
-0,0300
-1,64%
Сегодняшний диапазон
1,7550 - 1,9100
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
28 мар 2024 10:08:00 Источник NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
26 мар 2024 09:45:03 Источник NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
25 мар 2024 10:40:51 Источник NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
20 мар 2024 09:45:01 Источник NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
19 мар 2024 10:49:14 Источник NetDania Notify
-
19 мар 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
18 мар 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
12 мар 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
06 мар 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study
22 фев 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial
07 фев 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Issues Letter to Shareholders
09 янв 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director
04 дек 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial
20 ноя 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
13 ноя 2023 09:00:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Appoints Financial Executive Jonathan Finn to its Board of Directors
09 ноя 2023 09:00:00 Источник Nasdaq GlobeNewswire
-
Atossa to Present at Cantor Fitzgerald Global Healthcare Conference 2023
18 сен 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
14 авг 2023 08:30:03 Источник Nasdaq GlobeNewswire
-
08 авг 2023 09:00:00 Источник Nasdaq GlobeNewswire
-
20 июл 2023 09:15:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >